<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://wiki1.b.seossd.bitactive.com/index.php?action=history&amp;feed=atom&amp;title=Xarelto_Lawsuit%3A_The_Samurai_Way</id>
		<title>Xarelto Lawsuit: The Samurai Way - Revision history</title>
		<link rel="self" type="application/atom+xml" href="http://wiki1.b.seossd.bitactive.com/index.php?action=history&amp;feed=atom&amp;title=Xarelto_Lawsuit%3A_The_Samurai_Way"/>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Xarelto_Lawsuit:_The_Samurai_Way&amp;action=history"/>
		<updated>2026-06-18T00:00:58Z</updated>
		<subtitle>Revision history for this page on the wiki</subtitle>
		<generator>MediaWiki 1.29.0</generator>

	<entry>
		<id>http://wiki1.b.seossd.bitactive.com/index.php?title=Xarelto_Lawsuit:_The_Samurai_Way&amp;diff=170319&amp;oldid=prev</id>
		<title>TereseDaye6451 at 10:33, 22 April 2018</title>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Xarelto_Lawsuit:_The_Samurai_Way&amp;diff=170319&amp;oldid=prev"/>
				<updated>2018-04-22T10:33:41Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&#039;diff-marker&#039; /&gt;
				&lt;col class=&#039;diff-content&#039; /&gt;
				&lt;col class=&#039;diff-marker&#039; /&gt;
				&lt;col class=&#039;diff-content&#039; /&gt;
				&lt;tr style=&#039;vertical-align: top;&#039; lang=&#039;en&#039;&gt;
				&lt;td colspan=&#039;2&#039; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&#039;2&#039; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Revision as of 10:33, 22 April 2018&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&#039;diff-marker&#039;&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;individuals &lt;/del&gt;who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;businesses&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;including &lt;/del&gt;the makers of Xarelto, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;have &lt;/del&gt;a duty to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;make sure &lt;/del&gt;that their drugs are reasonably &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;protected &lt;/del&gt;for use - and failure to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;accomplish &lt;/del&gt;so may be grounds for compensation. Our lawyers are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;operating difficult &lt;/del&gt;to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;obtain these &lt;/del&gt;hurt by the drug the compensation they &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;are &lt;/del&gt;entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Whilst bleeding is really a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;common &lt;/del&gt;complication associated with anticoagulants, it has been alleged that Xarelto is &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;a lot &lt;/del&gt;more hazardous than &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;classic &lt;/del&gt;blood thinners since no antidote exists to reverse its blood-thinning effects. This &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;signifies &lt;/del&gt;that, inside the occasion of an emergency, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;individuals &lt;/del&gt;could be at threat for irreversible bleeding difficulties, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;including &lt;/del&gt;life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;If &lt;/del&gt;you or &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;perhaps &lt;/del&gt;a loved &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;a single &lt;/del&gt;suffered a significant bleeding event following taking Xarelto, you &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;may &lt;/del&gt;have legal recourse. For more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;details&lt;/del&gt;, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;get in touch &lt;/del&gt;with us &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;nowadays &lt;/del&gt;to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;have &lt;/del&gt;your case reviewed, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;totally &lt;/del&gt;free of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;seeking &lt;/del&gt;compensation from Bayer and Janssen for previous and future &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;health-related &lt;/del&gt;bills, lost wages, discomfort and suffering and, in &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;cases &lt;/del&gt;of death, funeral &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;costs&lt;/del&gt;. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Additionally&lt;/del&gt;, they may be &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;searching &lt;/del&gt;for punitive damages, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;that &lt;/del&gt;are &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;generally &lt;/del&gt;awarded to punish the defendant and deter other &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;firms &lt;/del&gt;from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Being &lt;/del&gt;Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;the drug is unsafe&amp;#160; &lt;/del&gt;[http://&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;149&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;202&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;141.216:8080&lt;/del&gt;/&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;index.php?title=User%3AMaikNobelius Http:&lt;/del&gt;//&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;149&lt;/del&gt;.&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;202.141.216&lt;/del&gt;] and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Because &lt;/del&gt;of this, the lawsuits claim, doctors have no effective &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;signifies &lt;/del&gt;of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;within &lt;/del&gt;the lawsuits allege &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;severe &lt;/del&gt;and fatal injuries, &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;such as [http://www.Caringbridge.org/search?q=cerebral%20hemorrhaging &lt;/del&gt;cerebral hemorrhaging&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;] &lt;/del&gt;and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;within &lt;/del&gt;the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;protected &lt;/del&gt;anticoagulant option.&amp;lt;br&amp;gt;Doctors and &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;medical &lt;/del&gt;staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;occasion&lt;/del&gt;.&amp;lt;br&amp;gt;Xarelto is linked to &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;serious &lt;/del&gt;bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;much &lt;/del&gt;more &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;information &lt;/del&gt;on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;within &lt;/del&gt;the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;&lt;/td&gt;&lt;td class=&#039;diff-marker&#039;&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;sufferers &lt;/ins&gt;who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;organizations&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;like &lt;/ins&gt;the makers of Xarelto, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;possess &lt;/ins&gt;a duty to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;ensure &lt;/ins&gt;that their drugs are reasonably &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;safe &lt;/ins&gt;for use - and failure to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;perform &lt;/ins&gt;so may &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;possibly &lt;/ins&gt;be grounds for &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[http://www.Blogrollcenter.com/index.php?a=search&amp;amp;q=compensation &lt;/ins&gt;compensation&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;]&lt;/ins&gt;. Our lawyers are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;working hard &lt;/ins&gt;to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;have those &lt;/ins&gt;hurt by the drug the compensation they&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;&amp;#039;re &lt;/ins&gt;entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Whilst bleeding is really a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;frequent &lt;/ins&gt;complication associated with anticoagulants, it has been alleged that Xarelto is &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;much &lt;/ins&gt;more hazardous than &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;conventional &lt;/ins&gt;blood thinners since no antidote exists to reverse its blood-thinning effects. This &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;means &lt;/ins&gt;that, inside the occasion of an emergency, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;patients &lt;/ins&gt;could be at threat for irreversible bleeding difficulties, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;which includes &lt;/ins&gt;life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;In the event &lt;/ins&gt;you or a loved &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;one &lt;/ins&gt;suffered a significant bleeding event following taking Xarelto, you &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;might &lt;/ins&gt;have legal recourse. For more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;data&lt;/ins&gt;, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;make contact &lt;/ins&gt;with us &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;right now &lt;/ins&gt;to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;possess &lt;/ins&gt;your case reviewed, free of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;searching for &lt;/ins&gt;compensation from Bayer and Janssen for previous and future &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;medical &lt;/ins&gt;bills, lost wages, discomfort and suffering and, in &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;situations &lt;/ins&gt;of death, funeral &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;expenses&lt;/ins&gt;. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Moreover&lt;/ins&gt;, they may be &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;looking &lt;/ins&gt;for punitive damages, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;which &lt;/ins&gt;are &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;typically &lt;/ins&gt;awarded to punish the defendant and deter other &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;companies &lt;/ins&gt;from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Becoming &lt;/ins&gt;Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that [http://&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;xareltoattorneys&lt;/ins&gt;.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;bitbucket&lt;/ins&gt;.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;org&lt;/ins&gt;/&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;categories&lt;/ins&gt;/&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;North-Dakota&lt;/ins&gt;/&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;index&lt;/ins&gt;.&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;html click the up coming website page&lt;/ins&gt;] &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;drug is hazardous &lt;/ins&gt;and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Due to the fact &lt;/ins&gt;of this, the lawsuits claim, doctors have no effective &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;implies &lt;/ins&gt;of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;in &lt;/ins&gt;the lawsuits allege &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/ins&gt;and fatal injuries, &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;like &lt;/ins&gt;cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;in &lt;/ins&gt;the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;secure &lt;/ins&gt;anticoagulant option.&amp;lt;br&amp;gt;Doctors and &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;healthcare &lt;/ins&gt;staff were not properly made aware of methods to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;[http://www.51Ideas.com/?s=&lt;/ins&gt;stabilize &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;stabilize] &lt;/ins&gt;and treat a Xarelto user inside the event of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;event&lt;/ins&gt;.&amp;lt;br&amp;gt;Xarelto is linked to &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;critical &lt;/ins&gt;bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for more &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;details &lt;/ins&gt;on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;in &lt;/ins&gt;the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>TereseDaye6451</name></author>	</entry>

	<entry>
		<id>http://wiki1.b.seossd.bitactive.com/index.php?title=Xarelto_Lawsuit:_The_Samurai_Way&amp;diff=38622&amp;oldid=prev</id>
		<title>DanutaMcCaughey: Created page with &quot;Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical busi...&quot;</title>
		<link rel="alternate" type="text/html" href="http://wiki1.b.seossd.bitactive.com/index.php?title=Xarelto_Lawsuit:_The_Samurai_Way&amp;diff=38622&amp;oldid=prev"/>
				<updated>2018-04-11T00:20:10Z</updated>
		
		<summary type="html">&lt;p&gt;Created page with &amp;quot;Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical busi...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered severe bleeding events. Pharmaceutical businesses, including the makers of Xarelto, have a duty to make sure that their drugs are reasonably protected for use - and failure to accomplish so may be grounds for compensation. Our lawyers are operating difficult to obtain these hurt by the drug the compensation they are entitled to.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Whilst bleeding is really a common complication associated with anticoagulants, it has been alleged that Xarelto is a lot more hazardous than classic blood thinners since no antidote exists to reverse its blood-thinning effects. This signifies that, inside the occasion of an emergency, individuals could be at threat for irreversible bleeding difficulties, including life-threatening internal and gastrointestinal hemorrhaging.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;If you or perhaps a loved a single suffered a significant bleeding event following taking Xarelto, you may have legal recourse. For more details, get in touch with us nowadays to have your case reviewed, totally free of charge.&amp;lt;br&amp;gt;Compensation Possibilities&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in cases of death, funeral costs. Additionally, they may be searching for punitive damages, that are generally awarded to punish the defendant and deter other firms from acting similarly.&amp;lt;br&amp;gt;Why Are Lawsuits Being Filed?&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe  [http://149.202.141.216:8080/index.php?title=User%3AMaikNobelius Http://149.202.141.216] and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the event of an emergency. Plaintiffs within the lawsuits allege severe and fatal injuries, such as [http://www.Caringbridge.org/search?q=cerebral%20hemorrhaging cerebral hemorrhaging] and gastrointestinal bleeds, from use of the drug.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;In addition to these risks, lawsuits against Bayer and Johnson &amp;amp; Johnson’s Janssen Pharmaceuticals are alleging:&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.&amp;lt;br&amp;gt;The makers of the drug continue to market Xarelto as a protected anticoagulant option.&amp;lt;br&amp;gt;Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user inside the event of a bleeding complication.&amp;lt;br&amp;gt;Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding occasion.&amp;lt;br&amp;gt;Xarelto is linked to serious bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing dangerous clotting.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Visit this page for much more information on the alleged health risks of Xarelto.&amp;lt;br&amp;gt;Multidistrict Litigation Trial Dates Set&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.&lt;/div&gt;</summary>
		<author><name>DanutaMcCaughey</name></author>	</entry>

	</feed>